Isracann Biosciences Inc (ISCNF)
0.00
USD |
OTCM |
May 06, 16:00
Isracann Biosciences Max Drawdown (5Y): 99.98% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 99.98% |
March 31, 2024 | 99.98% |
February 29, 2024 | 99.65% |
January 31, 2024 | 99.65% |
December 31, 2023 | 99.65% |
November 30, 2023 | 99.99% |
October 31, 2023 | 99.99% |
September 30, 2023 | 99.99% |
August 31, 2023 | 99.99% |
July 31, 2023 | 99.99% |
June 30, 2023 | 99.99% |
May 31, 2023 | 99.99% |
April 30, 2023 | 99.99% |
March 31, 2023 | 99.99% |
February 28, 2023 | 99.99% |
January 31, 2023 | 99.99% |
December 31, 2022 | 99.99% |
November 30, 2022 | 99.99% |
October 31, 2022 | 99.99% |
September 30, 2022 | 99.99% |
August 31, 2022 | 99.99% |
July 31, 2022 | 99.99% |
June 30, 2022 | 99.99% |
May 31, 2022 | 99.99% |
April 30, 2022 | 99.99% |
Date | Value |
---|---|
March 31, 2022 | 99.99% |
February 28, 2022 | 99.99% |
January 31, 2022 | 99.99% |
December 31, 2021 | 99.99% |
November 30, 2021 | 99.99% |
October 31, 2021 | 99.99% |
September 30, 2021 | 99.99% |
August 31, 2021 | 99.99% |
July 31, 2021 | 99.99% |
June 30, 2021 | 99.99% |
May 31, 2021 | 99.99% |
April 30, 2021 | 99.99% |
March 31, 2021 | 99.99% |
February 28, 2021 | 99.99% |
January 31, 2021 | 99.99% |
December 31, 2020 | 99.99% |
November 30, 2020 | 99.99% |
October 31, 2020 | 99.99% |
September 30, 2020 | 99.99% |
August 31, 2020 | 99.99% |
July 31, 2020 | 99.99% |
June 30, 2020 | 99.99% |
May 31, 2020 | 99.99% |
April 30, 2020 | 99.99% |
March 31, 2020 | 99.99% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
99.65%
Minimum
Dec 2023
99.99%
Maximum
May 2019
99.97%
Average
99.99%
Median
May 2019
Max Drawdown (5Y) Benchmarks
Acasti Pharma Inc | 98.73% |
Aurinia Pharmaceuticals Inc | 87.58% |
Edesa Biotech Inc | 99.58% |
Lexaria Bioscience Corp | 98.90% |
Liminal Biosciences Inc (DELISTED) | -- |